Finvio Logo
Finvio

Complete CGTX Stock Valuation Analysis

Comprehensive intrinsic value analysis using 1 different methodologies

CGTX Peer Valuation Analysis

Relative valuation based on comparable company trading multiples

Peer Valuation Analysis

Fair Value Range Analysis

Based on median multiples from 10 peer companies in Healthcare

P/E Ratio
$-32.92
-10961.2%
Peer Median: 61.1x
EV/EBITDA
$0.00
-100.0%
Peer Median: 44.7x
P/S Ratio
$0.00
-100.0%
Peer Median: 8.7x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for CGTX's business model and current situation.
Multiple Comparison
MultipleCGTX CurrentPeer MedianPeer AveragePremium/DiscountAssessment
P/E Ratio-0.6x61.1x31.0x-100.9%
Undervalued
EV/EBITDA-Infinityx44.7x23.6x-Infinity%
Undervalued
P/S RatioInfinityx8.7x7.6xInfinity%
Overvalued
Peer Companies
Click any company to view their valuation
CompanyMarket CapP/E RatioEV/EBITDAP/S Ratio
$0.02B0.0x0.0x733.2x
$0.02B0.0x0.0x4.8x
$0.01B0.0x0.0x8.7x
$0.02B0.0x0.0x27.3x
$0.02B0.0x0.0x0.0x
$0.02B0.0x0.0x0.0x
$0.02B0.0x0.0x33.7x
$0.02B0.8x2.6x2.4x
$0.02B0.0x0.0x0.0x
$714.38B61.1x44.7x14.6x